{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T17:53:49Z","timestamp":1780595629529,"version":"3.54.1"},"reference-count":87,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,27]],"date-time":"2024-06-27T00:00:00Z","timestamp":1719446400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["iScience"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.isci.2024.110426","type":"journal-article","created":{"date-parts":[[2024,7,2]],"date-time":"2024-07-02T17:06:45Z","timestamp":1719940005000},"page":"110426","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["A cyclic peptide-grafted Fc with hepatocyte growth factor functionality ameliorates hepatic fibrosis in a non-alcoholic steatohepatitis mouse model"],"prefix":"10.1016","volume":"27","author":[{"given":"Nichole Marcela","family":"Rojas-Chaverra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryu","family":"Imamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroki","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toby","family":"Passioura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emiko","family":"Mihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsunori","family":"Nishimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junichi","family":"Takagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Suga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunio","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0443-1786","authenticated-orcid":false,"given":"Katsuya","family":"Sakai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.isci.2024.110426_bib1","first-page":"87","article-title":"Cytokines and Growth Factors","volume":"171","author":"Silva","year":"2020","journal-title":"Adv. Biochem. Eng. Biotechnol."},{"key":"10.1016\/j.isci.2024.110426_bib2","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1002\/cyto.a.22161","article-title":"Functions of neurotrophins and growth factors in neurogenesis and brain repair","volume":"83","author":"Oliveira","year":"2013","journal-title":"Cytometry A."},{"key":"10.1016\/j.isci.2024.110426_bib3","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/s41573-022-00557-6","article-title":"Emerging principles of cytokine pharmacology and therapeutics","volume":"22","author":"Saxton","year":"2023","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.isci.2024.110426_bib4","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1016\/j.cell.2022.02.025","article-title":"Facile discovery of surrogate cytokine agonists","volume":"185","author":"Yen","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.isci.2024.110426_bib5","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aay2801","article-title":"A chemically unmodified agonistic DNA with growth factor functionality for in\u00a0vivo therapeutic application","volume":"6","author":"Ueki","year":"2020","journal-title":"Sci. Adv."},{"key":"10.1016\/j.isci.2024.110426_bib6","doi-asserted-by":"crossref","first-page":"10294","DOI":"10.1002\/anie.201611914","article-title":"New Modalities for Challenging Targets in Drug Discovery","volume":"56","author":"Valeur","year":"2017","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"10.1016\/j.isci.2024.110426_bib7","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines6040116","article-title":"Structural Features and Binding Modes of Thioether-Cyclized Peptide Ligands","volume":"6","author":"Otero-Ramirez","year":"2018","journal-title":"Biomedicines"},{"key":"10.1016\/j.isci.2024.110426_bib8","doi-asserted-by":"crossref","first-page":"6530","DOI":"10.1002\/chem.201300247","article-title":"Flexizyme-mediated genetic reprogramming as a tool for noncanonical peptide synthesis and drug discovery","volume":"19","author":"Passioura","year":"2013","journal-title":"Chemistry"},{"key":"10.1016\/j.isci.2024.110426_bib9","doi-asserted-by":"crossref","first-page":"10360","DOI":"10.1021\/acs.chemrev.8b00430","article-title":"RNA Display Methods for the Discovery of Bioactive Macrocycles","volume":"119","author":"Huang","year":"2019","journal-title":"Chem. Rev."},{"key":"10.1016\/j.isci.2024.110426_bib10","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1038\/s41551-022-00955-6","article-title":"Designing receptor agonists with enhanced pharmacokinetics by grafting macrocyclic peptides into fragment crystallizable regions","volume":"7","author":"Sakai","year":"2023","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.isci.2024.110426_bib11","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1038\/s41467-021-21875-0","article-title":"Lasso-grafting of macrocyclic peptide pharmacophores yields multi-functional proteins","volume":"12","author":"Mihara","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.isci.2024.110426_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2021.103302","article-title":"De novo peptide grafting to a self-assembling nanocapsule yields a hepatocyte growth factor receptor agonist","volume":"24","author":"Komatsu","year":"2021","journal-title":"iScience"},{"key":"10.1016\/j.isci.2024.110426_bib13","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1172\/JCI24282","article-title":"Liver fibrosis","volume":"115","author":"Bataller","year":"2005","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.isci.2024.110426_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.endmts.2021.100089","article-title":"The global epidemiology of nonalcoholic steatohepatitis (NASH) and associated risk factors\u2013A targeted literature review","volume":"3","author":"Dufour","year":"2021","journal-title":"Endocr. Metab. Sci."},{"key":"10.1016\/j.isci.2024.110426_bib15","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1002\/hep4.1479","article-title":"Pathogenesis of Nonalcoholic Steatohepatitis: An Overview","volume":"4","author":"Parthasarathy","year":"2020","journal-title":"Hepatol. Commun."},{"key":"10.1016\/j.isci.2024.110426_bib16","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.isci.2024.110426_bib17","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/s41575-020-00372-7","article-title":"Molecular and cellular mechanisms of liver fibrosis and its regression","volume":"18","author":"Kisseleva","year":"2021","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.isci.2024.110426_bib18","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1038\/s41401-021-00832-z","article-title":"NASH: regulatory considerations for clinical drug development and U.S. FDA approval","volume":"43","author":"Harvey","year":"2022","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.isci.2024.110426_bib19","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1038\/nrm3012","article-title":"MET signalling: principles and functions in development, organ regeneration and cancer","volume":"11","author":"Trusolino","year":"2010","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.isci.2024.110426_bib20","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1093\/jb\/mvv027","article-title":"Hepatocyte growth factor and Met in drug discovery","volume":"157","author":"Sakai","year":"2015","journal-title":"J.\u00a0Biochem."},{"key":"10.1016\/j.isci.2024.110426_bib21","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.jhep.2014.05.019","article-title":"Hepatocyte specific deletion of c-Met leads to the development of severe non-alcoholic steatohepatitis in mice","volume":"61","author":"Kroy","year":"2014","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.isci.2024.110426_bib22","first-page":"969","article-title":"The potential roles of hepatocyte growth factor (HGF)-MET pathway inhibitors in cancer treatment","volume":"7","author":"Parikh","year":"2014","journal-title":"OncoTargets Ther."},{"key":"10.1016\/j.isci.2024.110426_bib23","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/6957497","article-title":"c-Met Signaling Protects from Nonalcoholic Steatohepatitis- (NASH-) Induced Fibrosis in Different Liver Cell Types","volume":"2018","author":"Drescher","year":"2018","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.isci.2024.110426_bib24","doi-asserted-by":"crossref","first-page":"10608","DOI":"10.1073\/pnas.0403412101","article-title":"Met provides essential signals for liver regeneration","volume":"101","author":"Borowiak","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.isci.2024.110426_bib25","doi-asserted-by":"crossref","first-page":"G204","DOI":"10.1152\/ajpgi.00021.2007","article-title":"HGF ameliorates a high-fat diet-induced fatty liver","volume":"293","author":"Kosone","year":"2007","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.isci.2024.110426_bib26","doi-asserted-by":"crossref","first-page":"4357","DOI":"10.1073\/pnas.91.10.4357","article-title":"Hepatocyte growth factor prevents acute renal failure and accelerates renal regeneration in mice","volume":"91","author":"Kawaida","year":"1994","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.isci.2024.110426_bib27","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/j.1440-1681.2011.05483.x","article-title":"Recombinant human hepatocyte growth factor (HGF), but not rat HGF, elicits glomerular injury and albuminuria in normal rats via an immune complex-dependent mechanism","volume":"38","author":"Mizuno","year":"2011","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.isci.2024.110426_bib28","first-page":"503","article-title":"Repeated intravenous injection of recombinant human hepatocyte growth factor ameliorates liver cirrhosis but causes albuminuria in rats","volume":"17","author":"Kusumoto","year":"2006","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.isci.2024.110426_bib29","doi-asserted-by":"crossref","first-page":"378","DOI":"10.3389\/fendo.2018.00378","article-title":"Interventional Potential of Recombinant Feline Hepatocyte Growth Factor in a Mouse Model of Non-alcoholic Steatohepatitis","volume":"9","author":"Yang","year":"2018","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.isci.2024.110426_bib30","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/jdi.12904","article-title":"Hepatocyte growth factor alleviates hepatic insulin resistance and lipid accumulation in high-fat diet-fed mice","volume":"10","author":"Jing","year":"2019","journal-title":"J.\u00a0Diabetes Investig."},{"key":"10.1016\/j.isci.2024.110426_bib31","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1007\/s12072-011-9301-z","article-title":"Hepatocyte growth factor overexpression ameliorates liver inflammation and fibrosis in a mouse model of nonalcoholic steatohepatitis","volume":"6","author":"Tojima","year":"2012","journal-title":"Hepatol. Int."},{"key":"10.1016\/j.isci.2024.110426_bib32","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/7960386","article-title":"Hepatocyte Growth Factor Reduces Free Cholesterol-Mediated Lipotoxicity in Primary Hepatocytes by Countering Oxidative Stress","volume":"2016","author":"Dom\u00ednguez-P\u00e9rez","year":"2016","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.isci.2024.110426_bib33","doi-asserted-by":"crossref","first-page":"501","DOI":"10.5604\/01.3001.0011.7395","article-title":"Therapeutic Effect of HGF on NASH Mice Through HGF\/c-Met and JAK2-STAT3 Signalling Pathway","volume":"17","author":"Li","year":"2018","journal-title":"Ann. Hepatol."},{"key":"10.1016\/j.isci.2024.110426_bib34","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/iep.12008","article-title":"An improved mouse model that rapidly develops fibrosis in non-alcoholic steatohepatitis","volume":"94","author":"Matsumoto","year":"2013","journal-title":"Int. J. Exp. Pathol."},{"key":"10.1016\/j.isci.2024.110426_bib35","doi-asserted-by":"crossref","first-page":"6373","DOI":"10.1038\/ncomms7373","article-title":"Artificial human Met agonists based on macrocycle scaffolds","volume":"6","author":"Ito","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.isci.2024.110426_bib36","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1016\/j.str.2022.07.008","article-title":"De novo Fc-based receptor dimerizers differentially modulate PlexinB1 function","volume":"30","author":"Sugano-Nakamura","year":"2022","journal-title":"Structure"},{"key":"10.1016\/j.isci.2024.110426_bib37","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1038\/nri2155","article-title":"FcRn: the neonatal Fc receptor comes of age","volume":"7","author":"Roopenian","year":"2007","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.isci.2024.110426_bib38","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.addr.2015.02.005","article-title":"The neonatal Fc receptor, FcRn, as a target for drug delivery and therapy","volume":"91","author":"Sockolosky","year":"2015","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.isci.2024.110426_bib39","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1172\/JCI116673","article-title":"Keratinocyte growth factor and hepatocyte growth factor\/scatter factor are heparin-binding growth factors for alveolar type II cells in fibroblast-conditioned medium","volume":"92","author":"Panos","year":"1993","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.isci.2024.110426_bib40","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1093\/oxfordjournals.jbchem.a124958","article-title":"Hepatocyte growth factor suppresses the onset of liver cirrhosis and abrogates lethal hepatic dysfunction in rats","volume":"118","author":"Matsuda","year":"1995","journal-title":"J.\u00a0Biochem."},{"key":"10.1016\/j.isci.2024.110426_bib41","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1136\/gutjnl-2020-322786","article-title":"Mortality in biopsy-confirmed nonalcoholic fatty liver disease: results from a nationwide cohort","volume":"70","author":"Simon","year":"2021","journal-title":"Gut"},{"key":"10.1016\/j.isci.2024.110426_bib42","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1002\/hep.510270523","article-title":"Hepatocyte growth factor stimulates synthesis of lipids and secretion of lipoproteins in rat hepatocytes","volume":"27","author":"Kaibori","year":"1998","journal-title":"Hepatology"},{"key":"10.1016\/j.isci.2024.110426_bib43","first-page":"203","article-title":"High serum N-terminal propeptide of procollagen type III concentration is associated with liver diseases","volume":"12","author":"Gudowska","year":"2017","journal-title":"Prz. Gastroenterol."},{"key":"10.1016\/j.isci.2024.110426_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.108626","article-title":"Dynamic Shifts in the Composition of Resident and Recruited Macrophages Influence Tissue Remodeling in NASH","volume":"34","author":"Daemen","year":"2021","journal-title":"Cell Rep."},{"key":"10.1016\/j.isci.2024.110426_bib45","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0082163","article-title":"Hepatic crown-like structure: a unique histological feature in non-alcoholic steatohepatitis in mice and humans","volume":"8","author":"Itoh","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.isci.2024.110426_bib46","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/hep4.1801","article-title":"Role of Cholesterol-Associated Steatohepatitis in the Development of NASH","volume":"6","author":"Horn","year":"2022","journal-title":"Hepatol. Commun."},{"key":"10.1016\/j.isci.2024.110426_bib47","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1038\/s41575-021-00472-y","article-title":"Dietary carbohydrates and fats in nonalcoholic fatty liver disease","volume":"18","author":"Yki-J\u00e4rvinen","year":"2021","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.isci.2024.110426_bib48","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.jhepr.2019.10.008","article-title":"Lifestyle modification in NAFLD\/NASH: Facts and figures","volume":"1","author":"Hallsworth","year":"2019","journal-title":"JHEP Rep."},{"key":"10.1016\/j.isci.2024.110426_bib49","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.751802","article-title":"Role of Neutrophils in the Pathogenesis of Nonalcoholic Steatohepatitis","volume":"12","author":"Hwang","year":"2021","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.isci.2024.110426_bib50","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/j.bbadis.2018.01.019","article-title":"Inhibition of lysyl oxidase-like 1 (LOXL1) expression arrests liver fibrosis progression in cirrhosis by reducing elastin crosslinking","volume":"1864","author":"Zhao","year":"2018","journal-title":"Biochim. Biophys. Acta, Mol. Basis Dis."},{"key":"10.1016\/j.isci.2024.110426_bib51","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/j.ajpath.2019.04.004","article-title":"A Noncanonical Role for Plasminogen Activator Inhibitor Type 1 in Obesity-Induced Diabetes","volume":"189","author":"Coudriet","year":"2019","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.isci.2024.110426_bib52","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adf0133","article-title":"LOXL4, but not LOXL2, is the critical determinant of pathological collagen cross-linking and fibrosis in the lung","volume":"9","author":"Ma","year":"2023","journal-title":"Sci. Adv."},{"key":"10.1016\/j.isci.2024.110426_bib53","article-title":"A new mouse model of radiation-induced liver disease reveals mitochondrial dysfunction as an underlying fibrotic stimulus","volume":"4","author":"Melin","year":"2022","journal-title":"JHEP Rep."},{"key":"10.1016\/j.isci.2024.110426_bib54","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1111\/hepr.12787","article-title":"Role of thrombospondin 1 in liver diseases","volume":"47","author":"Li","year":"2017","journal-title":"Hepatol. Res."},{"key":"10.1016\/j.isci.2024.110426_bib55","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1248\/bpb.b15-00325","article-title":"Differential Roles of Angiogenesis in the Induction of Fibrogenesis and the Resolution of Fibrosis in Liver","volume":"38","author":"Park","year":"2015","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.isci.2024.110426_bib56","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.2337\/dc21-0131","article-title":"Circulating Thrombospondin-2 as a Novel Fibrosis Biomarker of Nonalcoholic Fatty Liver Disease in Type 2 Diabetes","volume":"44","author":"Lee","year":"2021","journal-title":"Diabetes Care"},{"key":"10.1016\/j.isci.2024.110426_bib57","article-title":"Elastin Fiber Accumulation in Liver Correlates with the Development of Hepatocellular Carcinoma","volume":"11","author":"Yasui","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.isci.2024.110426_bib58","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1002\/hep4.1381","article-title":"Liver Proliferation Is an Essential Driver of Fibrosis in Mouse Models of Nonalcoholic Fatty Liver Disease","volume":"3","author":"Cast","year":"2019","journal-title":"Hepatol. Commun."},{"key":"10.1016\/j.isci.2024.110426_bib59","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1002\/hep.31236","article-title":"Lysyl Oxidase (LOX) Family Members: Rationale and Their Potential as Therapeutic Targets for Liver Fibrosis","volume":"72","author":"Chen","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.isci.2024.110426_bib60","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1194\/jlr.M034876","article-title":"Hepatic cholesterol crystals and crown-like structures distinguish NASH from simple steatosis","volume":"54","author":"Ioannou","year":"2013","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.isci.2024.110426_bib61","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.yexmp.2015.06.015","article-title":"Fat-laden macrophages modulate lobular inflammation in nonalcoholic steatohepatitis (NASH)","volume":"99","author":"Jindal","year":"2015","journal-title":"Exp. Mol. Pathol."},{"key":"10.1016\/j.isci.2024.110426_bib62","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1038\/sj.onc.1205248","article-title":"Hepatocyte growth factor promotes hepatocarcinogenesis through c-Met autocrine activation and enhanced angiogenesis in transgenic mice treated with diethylnitrosamine","volume":"21","author":"Horiguchi","year":"2002","journal-title":"Oncogene"},{"key":"10.1016\/j.isci.2024.110426_bib63","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1007\/s10585-011-9404-x","article-title":"Hepatocyte growth factor upregulation promotes carcinogenesis and epithelial-mesenchymal transition in hepatocellular carcinoma via Akt and COX-2 pathways","volume":"28","author":"Ogunwobi","year":"2011","journal-title":"Clin. Exp. Metastasis"},{"key":"10.1016\/j.isci.2024.110426_bib64","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3389\/fcell.2020.00055","article-title":"The Function of the HGF\/c-Met Axis in Hepatocellular Carcinoma","volume":"8","author":"Wang","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.isci.2024.110426_bib65","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.jcmgh.2021.10.007","article-title":"A Novel Humanized Model of NASH and Its Treatment With META4, A Potent Agonist of MET","volume":"13","author":"Ma","year":"2022","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"key":"10.1016\/j.isci.2024.110426_bib66","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22126475","article-title":"FcRn as a Transporter for Nasal Delivery of Biologics: A Systematic Review","volume":"22","author":"Fieux","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.isci.2024.110426_bib67","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abb0580","article-title":"An engineered human albumin enhances half-life and transmucosal delivery when fused to protein-based biologics","volume":"12","author":"Bern","year":"2020","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.isci.2024.110426_bib68","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1089\/jam.2005.18.294","article-title":"Delivery of an erythropoietin-Fc fusion protein by inhalation in humans through an immunoglobulin transport pathway","volume":"18","author":"Dumont","year":"2005","journal-title":"J.\u00a0Aerosol Med."},{"key":"10.1016\/j.isci.2024.110426_bib69","doi-asserted-by":"crossref","first-page":"31070","DOI":"10.1073\/pnas.2012266117","article-title":"Development of cyclic peptides with potent in\u00a0vivo osteogenic activity through RaPID-based affinity maturation","volume":"117","author":"Bashiruddin","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.isci.2024.110426_bib70","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1248\/bpb.b19-00338","article-title":"Reduced Serum Cholesterol and Triglyceride Levels in a Choline-Deficient L-Amino Acid-Defined High-Fat Diet (CDAHFD)-Induced Mouse Model of Non-alcoholic Steatohepatitis (NASH)","volume":"43","author":"Yasuda","year":"2020","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.isci.2024.110426_bib71","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1194\/jlr.M800248-JLR200","article-title":"Blocking VLDL secretion causes hepatic steatosis but does not affect peripheral lipid stores or insulin sensitivity in mice","volume":"49","author":"Minehira","year":"2008","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.isci.2024.110426_bib72","first-page":"1","article-title":"Choline and Fructooligosaccharide: Non-alcoholic Fatty Liver Disease, Cardiac Fat Deposition, and Oxidative Stress Markers","volume":"8","author":"Borges Haubert","year":"2015","journal-title":"Nutr. Metab. Insights"},{"key":"10.1016\/j.isci.2024.110426_bib73","doi-asserted-by":"crossref","first-page":"410","DOI":"10.3389\/fphar.2018.00410","article-title":"Progression and Regression of Hepatic Lesions in a Mouse Model of NASH Induced by Dietary Intervention and Its Implications in Pharmacotherapy","volume":"9","author":"Ding","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.isci.2024.110426_bib75","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22179240","article-title":"Dimer Interface in Natural Variant NK1 Is Dispensable for HGF-Dependent Met Receptor Activation","volume":"22","author":"Tahira","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.isci.2024.110426_bib79","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s12938-016-0161-6","article-title":"Statistical colour models: an automated digital image analysis method for quantification of histological biomarkers","volume":"15","author":"Shu","year":"2016","journal-title":"Biomed. Eng. Online"},{"key":"10.1016\/j.isci.2024.110426_bib80","doi-asserted-by":"crossref","first-page":"i884","DOI":"10.1093\/bioinformatics\/bty560","article-title":"fastp: an ultra-fast all-in-one FASTQ preprocessor","volume":"34","author":"Chen","year":"2018","journal-title":"Bioinformatics"},{"key":"10.1016\/j.isci.2024.110426_bib81","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/nmeth.1923","article-title":"Fast gapped-read alignment with Bowtie 2","volume":"9","author":"Langmead","year":"2012","journal-title":"Nat. Methods"},{"key":"10.1016\/j.isci.2024.110426_bib82","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","article-title":"STAR: ultrafast universal RNA-seq aligner","volume":"29","author":"Dobin","year":"2013","journal-title":"Bioinformatics"},{"key":"10.1016\/j.isci.2024.110426_bib83","doi-asserted-by":"crossref","first-page":"e108","DOI":"10.1093\/nar\/gkt214","article-title":"The Subread aligner: fast, accurate and scalable read mapping by seed-and-vote","volume":"41","author":"Liao","year":"2013","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.isci.2024.110426_bib76","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1186\/s12859-018-2486-6","article-title":"iDEP: an integrated web application for differential expression and pathway analysis of RNA-Seq data","volume":"19","author":"Ge","year":"2018","journal-title":"BMC Bioinf."},{"key":"10.1016\/j.isci.2024.110426_bib84","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol."},{"key":"10.1016\/j.isci.2024.110426_bib85","doi-asserted-by":"crossref","first-page":"D605","DOI":"10.1093\/nar\/gkaa1074","article-title":"The STRING database in 2021: customizable protein-protein networks, and functional characterization of user-uploaded gene\/measurement sets","volume":"49","author":"Szklarczyk","year":"2021","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.isci.2024.110426_bib77","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1101\/gr.1239303","article-title":"Cytoscape: a software environment for integrated models of biomolecular interaction networks","volume":"13","author":"Shannon","year":"2003","journal-title":"Genome Res."},{"key":"10.1016\/j.isci.2024.110426_bib78","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1021\/acs.jproteome.8b00702","article-title":"Cytoscape StringApp: Network Analysis and Visualization of Proteomics Data","volume":"18","author":"Doncheva","year":"2019","journal-title":"J.\u00a0Proteome Res."},{"key":"10.1016\/j.isci.2024.110426_bib86","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1038\/nprot.2011.331","article-title":"Flexizymes for genetic code reprogramming","volume":"6","author":"Goto","year":"2011","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.isci.2024.110426_bib87","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1039\/C6CC06951G","article-title":"A RaPID way to discover nonstandard macrocyclic peptide modulators of drug targets","volume":"53","author":"Passioura","year":"2017","journal-title":"Chem. Commun."},{"key":"10.1016\/j.isci.2024.110426_bib74","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.pep.2014.01.009","article-title":"PA tag: a versatile protein tagging system using a\u00a0super high affinity antibody against a dodecapeptide derived from human podoplanin","volume":"95","author":"Fujii","year":"2014","journal-title":"Protein Expr. Purif."}],"container-title":["iScience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004224016511?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004224016511?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,12]],"date-time":"2024-11-12T16:20:54Z","timestamp":1731428454000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589004224016511"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":87,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["S2589004224016511"],"URL":"https:\/\/doi.org\/10.1016\/j.isci.2024.110426","relation":{},"ISSN":["2589-0042"],"issn-type":[{"value":"2589-0042","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A cyclic peptide-grafted Fc with hepatocyte growth factor functionality ameliorates hepatic fibrosis in a non-alcoholic steatohepatitis mouse model","name":"articletitle","label":"Article Title"},{"value":"iScience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.isci.2024.110426","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"110426"}}